科研之友
微信
新浪微博
Facebook
分享链接
摘要
Background: In the aging population cardiovascular disease (CVD) is highly prevalent. Identification of very old persons at high risk of recurrent CVD is difficult, since traditional risk markers loose predictive value with age. %26lt;br%26gt;Methods: In a population-based sample of 282 85-year old participants with established CVD from the Leiden 85-plus Study, we studied predictive values of traditional cardiovascular risk markers, a history of major CVD (myocardial infarction, stroke or arterial surgery), and new cardiovascular biomarkers (estimated glomerular filtration rate (MDRD), C-reactive protein (CRP), homocysteine and N-terminal pro B-type natriuretic peptide (NT-proBNP)) regarding 5-year risk of recurrent cardiovascular events and mortality (composite endpoint). %26lt;br%26gt;Results: During complete 5-year follow-up 157 (56%) participants died. 109 (39%) had a cardiovascular event or died from cardiovascular causes. Individually related to the composite endpoint were: a history of major CVD (HR 1.5 (95% CI 1.03-2.3)), CRP (HR 1.3 (95% CI 1.03-1.5)), homocysteine (HR 1.4 (95% CI 1.2-2.6)) and NT-proBNP (HR 1.7 (95% CI 1.4-2.1)). A prediction model including all traditional risk markers yielded a C-statistic of 0.59 (95% CI 0.52-0.66). Of all five new markers only addition of NT-proBNP improved the C-statistic (0.67 (95% CI 0.61-0.74, p=0.023)). The categoryless net reclassification improvement for NT-proBNP was 39% (p=0.001), for a history of major CVD 27.2% (p=0.03) and for homocysteine 24.7% (p=0.04). %26lt;br%26gt;Conclusions: Among very old subjects with established CVD, NT-proBNP was the strongest risk marker for cardiovascular events and cardiovascular mortality. When estimating risk in secondary prevention in very old age, use of NT-proBNP should be considered.
- 出版日期2013-11-21
